View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

SSA RIN: 0960-AF35 Publication ID: Fall 2013 
Title: Revised Medical Criteria for Evaluating Neurological Impairments (806P) 
Abstract: Sections 11.00 and 111.00, Neurological Impairments, of appendix 1 to subpart P of part 404 of our regulations describe neurological impairments that we consider severe enough to prevent a person from doing any gainful activity, or that cause marked and severe functional limitations for a child claiming Supplemental Security Income payments under title XVI. We are proposing to revise these sections to ensure that the medical evaluation criteria are up to date and consistent with the latest advances in medical knowledge and treatment. 
Agency: Social Security Administration(SSA)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 20 CFR 404.1500, app 1   
Legal Authority: 42 USC 402    42 USC 405(a)    42 USC 405(b)    42 USC 405(d) to 405(h)    42 USC 416(i)    42 USC 421(a)    42 USC 421(i)    42 USC 423    42 USC 902(a)(5)    42 USC 1381a    42 USC 1382c    42 USC 1383    42 USC 1383b   
Legal Deadline:  None

Statement of Need: These proposed regulations are necessary to update the listings for evaluating neurological impairments to reflect advances in medical knowledge, treatment, and methods of evaluating these impairments. The changes would ensure that determinations of disability have a sound medical basis, that claimants receive equal treatment through the use of specific criteria, and that people who are disabled can be readily identified and awarded benefits if all other factors of entitlement or eligibility are met.

Summary of the Legal Basis: Administrative--not required by statute or court order.

Alternatives: We considered not revising the listings and continuing to use our current criteria. However, we believe that proposing these revisions is preferable because of the medical advances that have been made in treating and evaluating these types of impairments.

Anticipated Costs and Benefits: Estimated Savings--low.

Risks: None.

Timetable:
Action Date FR Cite
ANPRM  04/13/2005  70 FR 19356   
ANPRM Comment Period End  06/13/2005    
NPRM  02/00/2014 
Additional Information: Includes Retrospective Review under E.O. 13563.
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: Yes 
Public Comment URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Cheryl A. Williams
Director
Social Security Administration
Office of Medical Policy, 6401 Security Boulevard,
Baltimore, MD 21235-6401
Phone:410 965-1020
Email: cheryl.a.williams@ssa.gov

Shawnette Ashburne
Social Insurance Specialist
Social Security Administration
Office of Medical Policy, 6401 Security Boulevard,
Baltimore, MD 21235-6401
Phone:410 966-5788

William P. Gibson
Social Insurance Specialist, Regulations Writer
Social Security Administration
Office of Regulations and Reports Clearance, 6401 Security Boulevard,
Baltimore, MD 21235-6401
Phone:410 966-9039
Email: william.gibson@ssa.gov